Audit 294884

FY End
2023-06-30
Total Expended
$44.37M
Findings
0
Programs
35
Year: 2023 Accepted: 2024-03-13

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
98.001 Microbicide R&d to Advance Hiv Prevention Technologies (matrix) $16.50M Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $701,111 Yes 0
93.310 Trans-Nih Research Support $419,424 Yes 0
93.396 Cancer Biology Research $348,610 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $323,140 Yes 0
12.420 Covid-19 Military Medical Research and Development $280,130 Yes 0
93.394 Cancer Detection and Diagnosis Research $222,561 Yes 0
93.393 Cancer Cause and Prevention Research $212,730 Yes 0
93.307 Minority Health and Health Disparities Research $199,824 Yes 0
93.864 Child Health and Human Development Extramural Research $167,870 Yes 0
93.000 Intraoperative Sampling of Fallopian Tubes $113,124 Yes 0
93.838 Maternal Microbial Metabolites $103,874 Yes 0
12.420 Military Medical Research and Development $102,639 Yes 0
93.866 Aging Research $96,553 Yes 0
93.000 Cerivical Cancer Cds Pilot $95,000 Yes 0
93.859 Biomedical Research and Research Training $89,916 Yes 0
93.855 Allergy and Infectious Diseases Research $83,061 Yes 0
93.000 O13b/c-Daily Oral Low Dose Ullipristal Acetate $81,891 Yes 0
98.001 Mosaic $80,807 Yes 0
93.103 Food and Drug Administration_research $80,715 Yes 0
93.279 Drug Abuse and Addiction Research Programs $59,658 Yes 0
93.000 A Randomized, Placebo-Controlled Trial of Tol-463 $45,178 Yes 0
93.433 Rehabilitation Research $44,949 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $32,464 Yes 0
93.350 National Center for Advancing Translational Sciences $29,209 Yes 0
93.865 Child Health and Human Development Extramural Research $26,293 Yes 0
93.395 Cancer Treatment Research $25,461 Yes 0
93.837 Cardiovascular Diseases Research $16,566 Yes 0
93.000 Contraceptive Development Program Nichd Female Sites $15,505 Yes 0
98.000 Usaid Foreign Assistance for Program Overseas $10,132 Yes 0
93.351 Research Infrastructure Programs $6,756 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $4,710 Yes 0
93.113 Environmental Health $2,944 Yes 0
93.000 Relief $2,037 Yes 0
93.398 Cancer Research Manpower $653 Yes 0

Contacts

Name Title Type
J3Z5MNJJ3FZ4 Timothy Bell Auditee
4126418957 Elizabeth E. Krisher Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: MWRIF has elected to not use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (Schedule) includes the federal award activity of Magee-Womens Research Institute and Foundation (MWRIF) under programs of the federal government for the year ended June 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of MWRIF, it is not intended to and does not present the financial position, changes in net assets, or cash flows of MWRIF.